Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients

John Morrison, Joseph Rogers, Stephen Scherr, Robert Benoit, Floyd E. Bloom

Research output: Contribution to journalArticle

194 Citations (Scopus)

Abstract

Senile dementia of the Alzheimer's type can be diagnosed with certainty only by examining neurofibrillary tangles and neuritic plaques under the microscope1-4. Recently, it has been suggested that the condition is linked to specific neurotransmitter systems5, with a decline of cortical acetylcholine, choline acetyl-transferase5-8, cholinergic neurones projecting to the cortex9-11, cortical noradrenaline content12, locus coeruleus neurones13,14 and cortical somatostatic content15. Using immunocytochemical methods 16, we here report that somatostatin-immunoreactive processes are present in neuritic plaques in human Alzheimer's specimens17. These data, as well as other reports of non-cholinergic changes18,19, strongly imply that Alzheimer's disease cannot be linked exclusively to cortical cholinergic elements, as proposed previously8. Rather, our data on plaque and somatostatin co-localization and distribution patterns suggest that Alzheimer's neuropathology may involve primarily the loss of selective cortical neurones that are targets of the implicated transmitter systems and that plaque formation may result from the degeneration of presynaptic and postsynaptic neurites of large projection neurones in layers III and V. Given the neurochemically heterogeneous input to these cells, it is not surprising that several neutrotransmitter systems, one of which is somatostatin, are implicated in the pathology of Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)90-92
Number of pages3
JournalNature
Volume314
Issue number6006
DOIs
StatePublished - Dec 1 1985
Externally publishedYes

Fingerprint

Amyloid Plaques
Somatostatin
Alzheimer Disease
Neurons
Neurofibrillary Tangles
Cholinergic Neurons
Locus Coeruleus
Neurites
Choline
Cholinergic Agents
Acetylcholine
Neurotransmitter Agents
Norepinephrine
Pathology

ASJC Scopus subject areas

  • Medicine(all)
  • General

Cite this

Morrison, J., Rogers, J., Scherr, S., Benoit, R., & Bloom, F. E. (1985). Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients. Nature, 314(6006), 90-92. https://doi.org/10.1038/314090a0

Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients. / Morrison, John; Rogers, Joseph; Scherr, Stephen; Benoit, Robert; Bloom, Floyd E.

In: Nature, Vol. 314, No. 6006, 01.12.1985, p. 90-92.

Research output: Contribution to journalArticle

Morrison, J, Rogers, J, Scherr, S, Benoit, R & Bloom, FE 1985, 'Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients', Nature, vol. 314, no. 6006, pp. 90-92. https://doi.org/10.1038/314090a0
Morrison, John ; Rogers, Joseph ; Scherr, Stephen ; Benoit, Robert ; Bloom, Floyd E. / Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients. In: Nature. 1985 ; Vol. 314, No. 6006. pp. 90-92.
@article{f6c308fbd5f94c17aed4baf2fbc10d81,
title = "Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients",
abstract = "Senile dementia of the Alzheimer's type can be diagnosed with certainty only by examining neurofibrillary tangles and neuritic plaques under the microscope1-4. Recently, it has been suggested that the condition is linked to specific neurotransmitter systems5, with a decline of cortical acetylcholine, choline acetyl-transferase5-8, cholinergic neurones projecting to the cortex9-11, cortical noradrenaline content12, locus coeruleus neurones13,14 and cortical somatostatic content15. Using immunocytochemical methods 16, we here report that somatostatin-immunoreactive processes are present in neuritic plaques in human Alzheimer's specimens17. These data, as well as other reports of non-cholinergic changes18,19, strongly imply that Alzheimer's disease cannot be linked exclusively to cortical cholinergic elements, as proposed previously8. Rather, our data on plaque and somatostatin co-localization and distribution patterns suggest that Alzheimer's neuropathology may involve primarily the loss of selective cortical neurones that are targets of the implicated transmitter systems and that plaque formation may result from the degeneration of presynaptic and postsynaptic neurites of large projection neurones in layers III and V. Given the neurochemically heterogeneous input to these cells, it is not surprising that several neutrotransmitter systems, one of which is somatostatin, are implicated in the pathology of Alzheimer's disease.",
author = "John Morrison and Joseph Rogers and Stephen Scherr and Robert Benoit and Bloom, {Floyd E.}",
year = "1985",
month = "12",
day = "1",
doi = "10.1038/314090a0",
language = "English (US)",
volume = "314",
pages = "90--92",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "6006",

}

TY - JOUR

T1 - Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients

AU - Morrison, John

AU - Rogers, Joseph

AU - Scherr, Stephen

AU - Benoit, Robert

AU - Bloom, Floyd E.

PY - 1985/12/1

Y1 - 1985/12/1

N2 - Senile dementia of the Alzheimer's type can be diagnosed with certainty only by examining neurofibrillary tangles and neuritic plaques under the microscope1-4. Recently, it has been suggested that the condition is linked to specific neurotransmitter systems5, with a decline of cortical acetylcholine, choline acetyl-transferase5-8, cholinergic neurones projecting to the cortex9-11, cortical noradrenaline content12, locus coeruleus neurones13,14 and cortical somatostatic content15. Using immunocytochemical methods 16, we here report that somatostatin-immunoreactive processes are present in neuritic plaques in human Alzheimer's specimens17. These data, as well as other reports of non-cholinergic changes18,19, strongly imply that Alzheimer's disease cannot be linked exclusively to cortical cholinergic elements, as proposed previously8. Rather, our data on plaque and somatostatin co-localization and distribution patterns suggest that Alzheimer's neuropathology may involve primarily the loss of selective cortical neurones that are targets of the implicated transmitter systems and that plaque formation may result from the degeneration of presynaptic and postsynaptic neurites of large projection neurones in layers III and V. Given the neurochemically heterogeneous input to these cells, it is not surprising that several neutrotransmitter systems, one of which is somatostatin, are implicated in the pathology of Alzheimer's disease.

AB - Senile dementia of the Alzheimer's type can be diagnosed with certainty only by examining neurofibrillary tangles and neuritic plaques under the microscope1-4. Recently, it has been suggested that the condition is linked to specific neurotransmitter systems5, with a decline of cortical acetylcholine, choline acetyl-transferase5-8, cholinergic neurones projecting to the cortex9-11, cortical noradrenaline content12, locus coeruleus neurones13,14 and cortical somatostatic content15. Using immunocytochemical methods 16, we here report that somatostatin-immunoreactive processes are present in neuritic plaques in human Alzheimer's specimens17. These data, as well as other reports of non-cholinergic changes18,19, strongly imply that Alzheimer's disease cannot be linked exclusively to cortical cholinergic elements, as proposed previously8. Rather, our data on plaque and somatostatin co-localization and distribution patterns suggest that Alzheimer's neuropathology may involve primarily the loss of selective cortical neurones that are targets of the implicated transmitter systems and that plaque formation may result from the degeneration of presynaptic and postsynaptic neurites of large projection neurones in layers III and V. Given the neurochemically heterogeneous input to these cells, it is not surprising that several neutrotransmitter systems, one of which is somatostatin, are implicated in the pathology of Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=0021988724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021988724&partnerID=8YFLogxK

U2 - 10.1038/314090a0

DO - 10.1038/314090a0

M3 - Article

VL - 314

SP - 90

EP - 92

JO - Nature

JF - Nature

SN - 0028-0836

IS - 6006

ER -